Recognizing October 9, 2026, as PANS/PANDAS Awareness Day in the State of New York
Summary
Assembly Resolution 1305 is a commemorative resolution that recognizes October 9, 2026, as PANS/PANDAS Awareness Day in New York State. The resolution describes PANS (Pediatric Acute-Onset Neuropsychiatric Syndrome) and PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) as serious pediatric conditions marked by the sudden onset of neuropsychiatric symptoms such as obsessive-compulsive behaviors, severe anxiety, tics, behavioral regression, and related cognitive and emotional difficulties.
The resolution emphasizes the importance of early recognition, accurate diagnosis, timely evidence-based treatment, and public education. It also highlights the impact of these conditions on children, families, caregivers, educators, and medical professionals, and frames the observance as an opportunity to reduce stigma, encourage research, and promote collaboration among stakeholders.
Impact
This resolution does not amend the New York Consolidated Laws or create regulatory requirements; instead, it adds a formal state observance and expresses legislative support for awareness of PANS/PANDAS. Its practical effect is symbolic and educational, aiming to elevate public understanding, encourage recognition of symptoms, and support affected families and professionals without changing substantive rights or obligations.
Sentiment
The tone of the resolution is strongly supportive and sympathetic toward children affected by PANS/PANDAS and the families and professionals who care for them. The bill text presents the observance as a positive awareness measure, and there is no recorded committee debate or vote history indicating opposition or controversy. Overall, the available context suggests a consensus-oriented, noncontroversial commemorative measure.
Contention
No specific points of contention are reflected in the available record because there are no committee transcripts, votes, or recorded amendments. If any concerns were to arise, they would likely relate to the medical characterization of PANS/PANDAS, the evidence base for diagnosis and treatment, or the value of state-recognized awareness days, but none of those issues are documented in the provided materials.